Key Links:
By Topic:
Search:
CROI 2006: Index of Coverage
Antiretrovirals in Development
- HIV Antiretroviral Agents in Development (March 30, 2006)
An overview from Edwin DeJesus, M.D.
From The Body - Merck, Gilead Release Strong Findings From Clinical Trials of Experimental Integrase Inhibitor Antiretroviral Drugs (February 9, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Complications of HIV/HAART
- Cardiovascular Risk and Antiretroviral Therapy: New Research on Epidemiology, Pathogenesis and Treatment (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - Interventions for Fat Changes: New Research on Glitazones, Metformin and Testosterone (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Link Between Tenofovir and Renal Toxicity Remains Tenuous, but Monitoring Is Warranted (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - Studies Large and Small Investigate Predictors of HIV-Related Neurocognitive Problems (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - Acid-Reducing Agents Reduce Atazanavir Drug Levels but Not Lopinavir/Ritonavir Levels (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - Antiretroviral Exposure Not Associated With Liver-Related Deaths in D:A:D Cohort (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - Incidence of AIDS-Associated and Non-AIDS-Associated Malignancies Among HIV-Infected Individuals (February 6, 2006)
Recent studies examine the risks for Kaposi's sarcoma, non-Hodgkin's lymphoma, cervical cancer, lung cancer and other malignancies.
In The 13th Conference on Retroviruses and Opportunistic Infections
Developing World
- Type of AIDS Infection Key to Death Risk -- Study (February 13, 2006)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - In Uganda, Three-NRTI Regimen Including Abacavir Is Better Tolerated Than Nevirapine-Based Regimen (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Drug Resistance
- More Sensitive Drug-Resistance Tests Yield Higher Rates of Multidrug Resistance in Treatment-Naive Patients (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - Transmission of Multidrug-Resistant HIV Will Not Become More Frequent in United Kingdom Through 2010, Statistical Model Suggests (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - Emtricitabine and Lamivudine May Be Similar, but Their Resistance Profiles Differ in Important Ways (February 6, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
HIV Transmission
- CROI 2006: Male Circumcision May Reduce Risk of HIV Transmission to Women (February 9, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Drug Combination Prevents HIV Infection in Monkeys (February 7, 2006)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Detecting Primary HIV Infection: Important for Prevention and, Extremely Rarely, Treatment as Well (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Treatment Strategies
- Starting HIV-Positive Patients on HAART Early Reduces Treatment-Related Complications, Study Finds (February 9, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Debate Over Antiretroviral Treatment Interruption Remains After Findings Show Method Increases HIV-Positive Patients' Risk of AIDS, Death (February 8, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - New Developments on Therapeutic Vaccines and Immune-Based Therapies for HIV Infection (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - Tipranavir Update at CROI 2006: RESIST Study Results, Drug Interactions and Therapeutic Drug Monitoring (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - Pharmacokinetic Data Show That Fosamprenavir + Atazanavir Combination Should Not Be Used (February 6, 2006)
However, boosting with atazanavir instead of ritonavir does appear feasible, this study finds.
In The 13th Conference on Retroviruses and Opportunistic Infections
Women and Pregnancy
- Nevirapine Reduces Risk of Mother-to-Child HIV Transmission in Repeat Pregnancies, Study Says (February 10, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - During the Third Trimester of Pregnancy Lopinavir/Ritonavir Dose Should Be Increased, Study Finds (February 6, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - PI-Based Therapy Does Not Increase Glucose Intolerance, Gestational Diabetes in Pregnant, HIV-Infected Women (February 6, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
  |